The following Structured Product Label (SPL) was submitted to the FDA by Oasis Trading for the product Aronamin Gold (NDC 72689-0024). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, inactive ingredient, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Fursultiamine(Active vitamin B1) 50.0mg
Riboflavin tetrabutyrate(Active vitamin B2) 2.5mg
Pyridoxal phosphate(Active vitamin B6) 2.5mg
Hydroxocobalamin acetate(Active vitamin B12) 5.22μg
Ascorbic acid(Vitamin C) 70mg
Tocopheryl acetate(Vitamin E) 20.0mg
Vitamines, Mineral & nutrients
Keep out of reach of children
Adults: take 1 tablet twice a day.
1) Do not take this medicine.
(1) Patients with hypersensitivity reactions to NSAIDs and the components contained in NSAIDs
(2) Infants under three months of age
(3) Because this drug contains lactose, patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption Do not administer.
2) Do not take the following medicine while taking this medicine.
(1) levodopa
3) Consult a doctor, dentist or pharmacist before taking this medicine.
(1) Patients receiving medical treatment
(2) patients with hyperoxaluria (excessive urinary excretion of urine)
(3) Pregnant women and possibly pregnant women, lactating women, premature infants, infants
(4) Patients with gout or kidney stones
4) Stop taking this drug immediately and consult a doctor, dentist, or pharmacist if you: Whenever possible, bring this attached document with you.
(1) If you have any of the following symptoms
Stomach discomfort, diarrhea, constipation, rash, fever, nausea, vomiting, dilated stool, stomatitis (mouth salt), anorexia, abdominal bloating
(2) Administration of this drug may result in faster or more frequent menstruation, and bleeding may last for a long time.
(3) The risk of thrombosis may be increased if a woman taking an oral contraceptive containing estrogen or a patient with thrombotic placenta is taking vitamin E.
(4) Long-term administration of high doses may result in resistance.
(5) Prolonged use of pyridoxine at a dose of 500 mg to 2 g / day may result in neuropathy or neuropathy (functional disorder or pathologic changes) in the peripheral nervous system.
(6) Hematologic adverse events may occur when vitamin B12 is administered at a dose of 10 μg or more per day in patients with insufficient folic acid.
5) Other Precautions for Taking
(1) Keep the prescribed dosage and dosage.
(2) it may interfere with the detection of blood glucose during various urine tests
(3) The urine may turn yellow, which may affect the clinical examination
6) Storage Precautions
(1) Keep out of the reach of children.
(2) Avoid direct sunlight. Store in a cool, dry place.
(3) To prevent misuse (misuse) and to preserve quality, please do not put in another container.
Microcrystalline Cellulose, Magnesium Stearate, Crospovidone, Copovidone, Colloidal Silicon Dioxide, OY-25014, OY-S-29019
For oral use only
* Please review the disclaimer below.
